Financial Performance and Subsidiaries Revenue
QUARTERLY FINANCIAL SUMMARY
NATCO
Revenue Division
SEGMENTAL BREAKDOWN (IN MILLION)
Q1FY24 Q1FY23
CONSOLIDATED FINANCIAL RESULTS (IN MILLION)
FY 23
FY22
A) API Revenue(¹):-
751
508
2,103
2,481
Total Revenues
Q1FY24 Q1FY23
11,602 9,189
28,117
20,438
FY 23
FY22
B) Formulation:-
EBITDA
5,477
4,296
10,402
3,625
B1) Formulation - Exports
(incl profit
share, license income, export service
income & Subsidiaries)
8,842
7,369
20,632
11,842
EBITDA Margin (%)
47.2%
46.8%
37.0%
17.7%
B2) Formulation - Domestic
1,324
885
3,749
4,771
Profit for the period (PAT)
4,203
3,204
7,153
1,700
Formulations Total Revenue (B1+B2)
10,166
8,254 24,381
16,612
PAT Margin (%)
36.2%
34.9%
25.4%
8.3%
C) Crop Health Sciences
447
10
409
51
D) Other Operating & Non - operating
incomes
238
417
1,224
1,293
Consolidated Total Revenue
11,602
9,189
28,117
20,438
14View entire presentation